Linnemann C C, Dine M S, Roselle G A, Askey P A
Pediatrics. 1982 Mar;69(3):332-5.
Measles immunity was studied in children in a private pediatric practice who had been revaccinated because they had received their primary measles vaccination before 1 year of age. Antibody was measured in 72 of these children who had received the first injection of live measles virus vaccine at less than 10 months of age, and the second at greater than 1 year of age. Of the 72 children, 29 (40%) had no detectable antibody and the geometric mean titer for the group was approximately 1:4. Of the children with low antibody titers, 15 were given a third injection of measles vaccine and five (33%) still did not respond. Cell-mediated immunity as indicated by lymphocyte transformation to measles antigen was measured in 11 of the children. Five (45%) had responses to measles antigen, but the responses did not correlate with the presence or absence of antibody. This study confirms the observation that revaccination is unsuccessful in many children who received measles vaccine in the first year of life, and shows that even a third injection of vaccine may fail to produce a significant antibody response.
在一家私立儿科诊所中,对因在1岁前接受过麻疹初种疫苗而进行复种的儿童的麻疹免疫力进行了研究。对其中72名在10个月龄前接种了第一剂麻疹活病毒疫苗、在1岁后接种了第二剂的儿童进行了抗体检测。在这72名儿童中,29名(40%)检测不到抗体,该组的几何平均滴度约为1:4。在抗体滴度较低的儿童中,15名儿童接种了第三剂麻疹疫苗,其中5名(33%)仍无反应。对11名儿童检测了淋巴细胞对麻疹抗原的转化所表明的细胞介导免疫。5名(45%)儿童对麻疹抗原有反应,但这些反应与抗体的有无无关。这项研究证实了这样的观察结果:在生命第一年接种麻疹疫苗的许多儿童中,复种是不成功的,并且表明即使接种第三剂疫苗也可能无法产生显著的抗体反应。